Skip to main content
logo
DHG Pharmaceutical JSC (HOSE:DHG)
Vietnam flag Vietnam · Delayed Price · Currency is VND
95,900
0.00 (0.00%)
At close: Sep 3, 2026

DHG Pharmaceutical JSC Balance Sheet

Millions VND. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
181,908129,89662,85894,13434,01843,374
Short-Term Investments
1,582,9182,024,0002,745,0001,960,0002,265,0001,975,000
Cash & Short-Term Investments
1,764,8262,153,8962,807,8582,054,1342,299,0182,018,374
Cash Growth
-30.93%-23.29%36.69%-10.65%13.90%-1.40%
Accounts Receivable
620,691584,930523,860528,859279,862315,113
Other Receivables
18,20379,72686,83896,07581,41777,757
Receivables
638,894664,792610,955625,192361,537393,141
Inventory
1,236,1961,024,6191,115,4291,534,6361,250,8341,072,606
Prepaid Expenses
19,1849,9968,6538,00710,2015,827
Other Current Assets
85,45235,46661,109420,224297,183237,346
Total Current Assets
3,744,5533,888,7684,604,0044,642,1934,218,7723,727,293
Property, Plant & Equipment
991,0941,012,5671,066,3751,187,884678,171631,658
Long-Term Investments
4,3504,6304,4384,1753,8604,578
Other Intangible Assets
173,025174,420178,106181,861201,812205,780
Long-Term Deferred Tax Assets
26,46225,92918,34016,87215,84517,535
Long-Term Deferred Charges
30,677-----
Other Long-Term Assets
35,32767,56787,98277,48949,72630,822
Total Assets
5,005,4885,173,8825,959,2436,110,4745,168,1874,617,666

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
322,427391,631167,297217,976364,379201,220
Accrued Expenses
382,385432,467339,445313,579227,615257,956
Short-Term Debt
--649,914572,165114,723207,391
Current Income Taxes Payable
30,4765,27222,41717,36512,6784,208
Current Unearned Revenue
46,76642,84248,50743,70234,04349,609
Other Current Liabilities
732,23893,737562,71324,45458,09837,332
Total Current Liabilities
1,514,292965,9501,790,2931,189,242811,537757,716
Other Long-Term Liabilities
72,61770,66774,19568,29865,11366,807
Total Liabilities
1,586,9091,036,6161,864,4881,257,540876,650824,523

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
1,307,4611,307,4611,307,4611,307,4611,307,4611,307,461
Additional Paid-In Capital
6,7796,7796,7796,7796,7796,779
Retained Earnings
2,104,3392,823,0262,780,5153,538,6952,977,2972,475,770
Total Common Equity
3,418,5794,137,2654,094,7554,852,9354,291,5373,790,010
Minority Interest
-----3,134
Shareholders' Equity
3,418,5794,137,2654,094,7554,852,9354,291,5373,793,144
Total Liabilities & Equity
5,005,4885,173,8825,959,2436,110,4745,168,1874,617,666

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
--649,914572,165114,723207,391
Net Cash (Debt)
1,764,8262,153,8962,157,9441,481,9692,184,2941,810,982
Net Cash Growth
8.42%-0.19%45.61%-32.15%20.61%-1.30%
Net Cash Per Share
13498.1216473.8816504.8411334.7216706.3913851.14
Filing Date Shares Outstanding
130.75130.75130.75130.75130.75130.75
Total Common Shares Outstanding
130.75130.75130.75130.75130.75130.75
Working Capital
2,230,2612,922,8192,813,7113,452,9513,407,2362,969,577
Book Value Per Share
26146.7031643.5131318.3837117.2532823.4528987.56
Tangible Book Value
3,245,5543,962,8453,916,6494,671,0744,089,7253,584,230
Tangible Book Value Per Share
24823.3430309.4829956.1535726.3131279.9127413.67
Buildings
778,420776,236776,502575,489578,613528,464
Machinery
1,451,9631,423,7341,374,8261,029,566903,189866,975
Construction In Progress
50,27744,15848,614553,59492,59669,508